Menu Philippe 4

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on 2026-06-12 in open-market transactions. The weighted-average price reported was $4.95 per share, for total proceeds of $24,752. The filing (acc. 0001840706-26-000209) was submitted on 2026-06-15.

Key Details

• Transaction date: 2026-06-12 (filed 2026-06-15) — filing appears timely.
• Type: Sale (open market) — 5,000 shares disposed.
• Price: weighted average $4.95; individual sale prices ranged $4.81–$5.15 (report notes multiple trades).
• Total reported proceeds: $24,752.
• Shares owned after transaction: not disclosed in the excerpt provided.
• Footnotes: Transaction executed pursuant to a pre-established Rule 10b5-1(c) trading plan (F1). Footnote F2 notes the weighted-average price and that the filer will provide per-price sale breakdown upon written request.
• Remarks reiterate the trade was under a 10b5-1 plan.

Context

• Sales under 10b5-1 plans are typically pre-arranged and can be routine, so they do not necessarily indicate a change in the insider’s view of the company. For retail investors, purchases are generally more informative than routine sales; this filing documents a routine, plan-driven sale.